全文获取类型
收费全文 | 2113篇 |
免费 | 157篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 37篇 |
妇产科学 | 56篇 |
基础医学 | 235篇 |
口腔科学 | 33篇 |
临床医学 | 449篇 |
内科学 | 385篇 |
皮肤病学 | 26篇 |
神经病学 | 214篇 |
特种医学 | 168篇 |
外科学 | 253篇 |
综合类 | 22篇 |
预防医学 | 128篇 |
眼科学 | 41篇 |
药学 | 103篇 |
中国医学 | 3篇 |
肿瘤学 | 98篇 |
出版年
2023年 | 12篇 |
2022年 | 25篇 |
2021年 | 72篇 |
2020年 | 36篇 |
2019年 | 73篇 |
2018年 | 64篇 |
2017年 | 46篇 |
2016年 | 62篇 |
2015年 | 64篇 |
2014年 | 70篇 |
2013年 | 116篇 |
2012年 | 136篇 |
2011年 | 149篇 |
2010年 | 72篇 |
2009年 | 67篇 |
2008年 | 101篇 |
2007年 | 113篇 |
2006年 | 104篇 |
2005年 | 105篇 |
2004年 | 88篇 |
2003年 | 82篇 |
2002年 | 86篇 |
2001年 | 46篇 |
2000年 | 48篇 |
1999年 | 20篇 |
1998年 | 26篇 |
1997年 | 16篇 |
1996年 | 13篇 |
1995年 | 18篇 |
1994年 | 12篇 |
1993年 | 21篇 |
1992年 | 34篇 |
1991年 | 20篇 |
1990年 | 24篇 |
1989年 | 19篇 |
1988年 | 18篇 |
1987年 | 18篇 |
1986年 | 19篇 |
1985年 | 13篇 |
1984年 | 9篇 |
1983年 | 6篇 |
1982年 | 7篇 |
1976年 | 5篇 |
1973年 | 7篇 |
1972年 | 7篇 |
1933年 | 5篇 |
1932年 | 5篇 |
1927年 | 6篇 |
1925年 | 10篇 |
1919年 | 4篇 |
排序方式: 共有2272条查询结果,搜索用时 15 毫秒
91.
James K. Min Troy M. Labounty Millie J. Gomez Stephan Achenbach Mouaz Al-Mallah Matthew J. Budoff Filippo Cademartiri Tracy Q. Callister Hyuk-Jae Chang Victor Cheng Kavitha M. Chinnaiyan Benjamin Chow Ricardo Cury Augustin Delago Allison Dunning Gudrun Feuchtner Martin Hadamitzky Jorg Hausleiter Philipp Kaufmann Yong-Jin Kim Jonathon Leipsic Fay Y. Lin Erica Maffei Gilbert Raff Leslee J. Shaw Todd C. Villines Daniel S. Berman 《Atherosclerosis》2014
Background
Coronary artery disease (CAD) diagnosis by coronary computed tomographic angiography (CCTA) is useful for identification of symptomatic diabetic individuals at heightened risk for death. Whether CCTA-detected CAD enables improved risk assessment of asymptomatic diabetic individuals beyond clinical risk factors and coronary artery calcium scoring (CACS) remains unexplored.Methods
From a prospective 12-center international registry of 27,125 individuals undergoing CCTA, we identified 400 asymptomatic diabetic individuals without known CAD. Coronary stenosis by CCTA was graded as 0%, 1–49%, 50–69%, and ≥70%. CAD was judged on a per-patient, per-vessel and per-segment basis as maximal stenosis severity, number of vessels with ≥50% stenosis, and coronary segments weighted for stenosis severity (segment stenosis score), respectively. We assessed major adverse cardiovascular events (MACE) – inclusive of mortality, nonfatal myocardial infarction (MI), and late target vessel revascularization ≥90 days (REV) – and evaluated the incremental utility of CCTA for risk prediction, discrimination and reclassification.Results
Mean age was 60.4 ± 9.9 years; 65.0% were male. At a mean follow-up 2.4 ± 1.1 years, 33 MACE occurred (13 deaths, 8 MI, 12 REV) [8.25%; annualized rate 3.4%]. By univariate analysis, per-patient maximal stenosis [hazards ratio (HR) 2.24 per stenosis grade, 95% confidence interval (CI) 1.61–3.10, p < 0.001], increasing numbers of obstructive vessels (HR 2.30 per vessel, 95% CI 1.75–3.03, p < 0.001) and segment stenosis score (HR 1.14 per segment, 95% CI 1.09–1.19, p < 0.001) were associated with increased MACE. After adjustment for CAD risk factors and CACS, maximal stenosis (HR 1.80 per grade, 95% CI 1.18–2.75, p = 0.006), number of obstructive vessels (HR 1.85 per vessel, 95% CI 1.29–2.65, p < 0.001) and segment stenosis score (HR 1.11 per segment, 95% CI 1.05–1.18, p < 0.001) were associated with increased risk of MACE. Beyond age, gender and CACS (C-index 0.64), CCTA improved discrimination by maximal stenosis, number of obstructive vessels and segment stenosis score (C-index 0.77, 0.77 and 0.78, respectively). Similarly, CCTA findings improved risk reclassification by per-patient maximal stenosis [integrated discrimination improvement (IDI) index 0.03, p = 0.03] and number of obstructive vessels (IDI index 0.06, p = 0.002), and by trend for segment stenosis score (IDI 0.03, p = 0.06).Conclusion
For asymptomatic diabetic individuals, CCTA measures of CAD severity confer incremental risk prediction, discrimination and reclassification on a per-patient, per-vessel and per-segment basis. 相似文献92.
93.
94.
James K. Min Reza Arsanjani Sachio Kurabayashi Daniele Andreini Gianluca Pontone Byung-Wook Choi Hyuk-Jae Chang Bin Lu Jagat Narula Afshin Karimi Carl Roobottom Millie Gomez Daniel S. Berman Ricardo C. Cury Todd Villines Joon Kang Jonathon Leipsic 《Journal of Cardiovascular Computed Tomography》2013,7(3):200-206
BackgroundCoronary CT angiography (CTA) has emerged as an effective noninvasive method for direct visualization of the coronary arteries, with high diagnostic performance compared with invasive coronary angiography (ICA). However, coronary CTA is prone to artifacts, including coronary motion, which may reduce its diagnostic performance. Intracycle motion compensation algorithms (MCAs) from a combination of software and hardware techniques now allow for correction of coronary motion, but the diagnostic performance of MCAs compared with traditional coronary CTA reconstruction methods remains unexplored.MethodsViCTORY (Validation of an Intracycle CT Motion CORrection Algorithm for Diagnostic AccuracY) is a prospective international multicenter trial of 218 patients which is designed to evaluate the performance of MCAs for the diagnosis of anatomically obstructive coronary artery disease (CAD) compared with an ICA reference standard, on a per-patient, per-vessel, and per-segment basis. Patients enrolled into ViCTORY will undergo investigational coronary CTA and clinically indicated ICA and will not receive heart rate-lowering medications before coronary CTA. Coronary CTA images will be reconstructed by conventional standard methods as well as by MCAs. Blinded core laboratory interpretation will be performed for coronary CTA and ICA in an intent-to-diagnose fashion.ResultsThe primary end point of ViCTORY is the per-patient diagnostic accuracy of MCAs for the diagnosis of anatomically obstructive CAD compared with ICA. Secondary end points will include other per-patient, per-vessel, and per-segment diagnostic performance characteristics, including accuracy, sensitivity, specificity, positive predictive value, and negative predictive value. Other key secondary end points will include diagnostic interpretability, image quality, the upper heart rate threshold of utility of MCAs, and the additive value of MCAs to traditionally reconstructed coronary CTA.ConclusionViCTORY will determine whether MCAs improve the diagnosis of obstructive CAD in patients undergoing coronary CTA who are not receiving heart rate-lowering medications. 相似文献
95.
Transfusion therapy in emergency medicine 总被引:1,自引:0,他引:1
M S Kruskall P D Mintz J J Bergin M F Johnston H G Klein J D Miller R Rutman L Silberstein 《Annals of emergency medicine》1988,17(4):327-335
Volume replacement is critical to the resuscitation of the hemorrhaging patient, but this usually can be accomplished quickly and safely with crystalloid and/or colloid solutions. Red cells should be used in addition to asanguinous fluids in the treatment of tissue hypoxia due to anemia. The need for whole blood as opposed to packed red blood cells is controversial. However, plasma should not be used as a volume expander, and its use to supplement coagulation factors during the massive transfusion of red cells should be guided by laboratory tests that document a coagulopathy. Similarly, platelet transfusions are indicated to correct documented thrombocytopenia or platelet dysfunction, and routine prophylaxis after fixed volumes of red cells results is unwarranted. Many anticipated complications of massive transfusions, including hemostatic abnormalities, acid-base imbalances, hyperkalemia, and hypocalcemia, are uncommon or of limited clinical significance. The risks of immune hemolysis and transfusion-transmitted diseases, on the other hand, are significant, and argue for judicious use of blood components. In emergencies in which blood is required immediately before compatibility testing can be completed, O-negative uncrossmatched blood can be requested. Careful blood specimen collection and patient identification prior to transfusion are critical. Practices that emphasize blood conservation, including the use of autologous salvaged blood, are always to the patient's advantage. 相似文献
96.
97.
Coronary computed tomography angiography (CCTA) is becoming an increasingly robust tool in the assessment and exclusion of coronary artery disease. Multiple recent studies have raised concerns regarding the radiation dose exposure of CCTA. A novel approach to dose reduction in CCTA using adaptive statistical iterative reconstruction, resulting in a submillisievert CCTA examination, is described. To the authors’ knowledge, the present report describes the first submillisievert study performed in Canada. The ability to perform a diagnostic CCTA with such a low dose challenges the role of coronary calcium scoring and will likely have implications for the future use of this test. 相似文献
98.
99.
100.